JP2005526813A5 - - Google Patents

Download PDF

Info

Publication number
JP2005526813A5
JP2005526813A5 JP2003580313A JP2003580313A JP2005526813A5 JP 2005526813 A5 JP2005526813 A5 JP 2005526813A5 JP 2003580313 A JP2003580313 A JP 2003580313A JP 2003580313 A JP2003580313 A JP 2003580313A JP 2005526813 A5 JP2005526813 A5 JP 2005526813A5
Authority
JP
Japan
Prior art keywords
hydrogen
group
independently
heteroarylalkyl
heteroalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003580313A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005526813A (ja
JP4610197B2 (ja
Filing date
Publication date
Priority claimed from AUPS1434A external-priority patent/AUPS143402A0/en
Application filed filed Critical
Publication of JP2005526813A publication Critical patent/JP2005526813A/ja
Publication of JP2005526813A5 publication Critical patent/JP2005526813A5/ja
Application granted granted Critical
Publication of JP4610197B2 publication Critical patent/JP4610197B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003580313A 2002-03-28 2003-03-28 単糖のアノマー誘導体 Expired - Fee Related JP4610197B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPS1434A AUPS143402A0 (en) 2002-03-28 2002-03-28 Anomeric derivatives of monosaccharides
AUPS1434 2002-03-28
PCT/AU2003/000384 WO2003082846A1 (en) 2002-03-28 2003-03-28 Anomeric derivatives of monosaccharides

Publications (3)

Publication Number Publication Date
JP2005526813A JP2005526813A (ja) 2005-09-08
JP2005526813A5 true JP2005526813A5 (enExample) 2006-03-16
JP4610197B2 JP4610197B2 (ja) 2011-01-12

Family

ID=3835023

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003580313A Expired - Fee Related JP4610197B2 (ja) 2002-03-28 2003-03-28 単糖のアノマー誘導体

Country Status (8)

Country Link
US (1) US7737287B2 (enExample)
EP (1) EP1487812A4 (enExample)
JP (1) JP4610197B2 (enExample)
CN (1) CN100537556C (enExample)
AU (1) AUPS143402A0 (enExample)
CA (1) CA2480578C (enExample)
DE (1) DE03745223T1 (enExample)
WO (1) WO2003082846A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138531B2 (en) 2001-10-15 2006-11-21 Kemin Pharma B.V.B.A. Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
AU2002950657A0 (en) 2002-08-08 2002-09-12 Alchemia Limited Derivatives of monosaccharides for drug discovery
AU2002951995A0 (en) 2002-10-11 2002-10-31 Alchemia Limited Classes of compounds that interact with gpcrs
CN100347184C (zh) 2003-01-07 2007-11-07 凯敏制药欧洲股份有限公司 可用于治疗由黄病毒科病毒如丙型肝炎及牛病毒性腹泻病毒引起的感染的双环糖类化合物
WO2004062590A2 (en) 2003-01-07 2004-07-29 Kemin Pharma Europe B.V.B.A. Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites
US7368475B2 (en) 2003-03-12 2008-05-06 Kemin Pharma Bvba Furanose-type bicyclic carbohydrates with biological activity
US7098243B2 (en) 2003-09-16 2006-08-29 Kemin Pharma Europe B.V.B.A. Bicyclic carbohydrates as antiviral bioactives for the treatment of infections caused by the alphaherpesvirinae HSV-1 and HSV-2
US20080176936A1 (en) * 2005-02-04 2008-07-24 Wim Meutermans Classes of Compounds that Interact with Integrins
AU2006209794B2 (en) * 2005-02-04 2010-07-08 Alchemia Limited Classes of compounds that interact with integrins
ES2400509T3 (es) * 2005-10-04 2013-04-10 Alchemia Ltd Método de diseño de fármacos
WO2007070947A1 (en) * 2005-12-22 2007-06-28 Alchemia Ltd Antibacterial agents
AU2021213822A1 (en) 2020-01-31 2022-09-22 Avilar Therapeutics, Inc. ASGPR-binding compounds for the degradation of extracellular proteins
TW202308703A (zh) 2021-05-03 2023-03-01 美商亞維拉治療公司 用於降解免疫球蛋白及其他蛋白質之有效asgpr結合化合物
WO2024118503A1 (en) 2022-11-28 2024-06-06 Hongene Biotech Corporation Functionalized n-acetylgalactosamine analogs

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5331664A (en) * 1976-09-02 1978-03-25 Suami T Production of novel nitroso urea derivatives
DE3347522A1 (de) * 1983-12-30 1985-07-11 Troponwerke GmbH & Co KG, 5000 Köln N-glycosylierte carbonsaeureamid-derivate als mittel bei der bekaempfung von erkrankungen des rheumatischen formenkreises
DE3521994A1 (de) * 1985-06-20 1987-01-02 Bayer Ag N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
HU208146B (en) * 1989-11-14 1993-08-30 Biogal Gyogyszergyar Process for producing aminobenzoic acid-n-glycoside derivatives
US5449785A (en) * 1991-07-24 1995-09-12 Hoffmann-La Roche Inc. Cyclohexane derivatives
JPH07242684A (ja) * 1994-03-02 1995-09-19 Japan Tobacco Inc 新規なグルクロン酸化合物
US5491152A (en) * 1994-03-23 1996-02-13 The Du Pont Merck Pharmaceutical Company Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis
AU7286696A (en) * 1995-10-13 1997-05-07 F. Hoffmann-La Roche Ag Antisense oligomers
AUPO190596A0 (en) * 1996-08-26 1996-09-19 Alchemia Pty Ltd Oligosaccharide synthesis
EP0998280A4 (en) * 1997-05-29 2002-11-06 Incara Pharmaceuticals Corp CARBOHYDRATE COMPOUNDS WITH SCAFFOLDING STRUCTURE AND BANKS CONTAINING SAME
US6197963B1 (en) * 1998-08-13 2001-03-06 The Trustees Of The University Of Pennsylvania Non-peptide peptidomimetics
CA2415368A1 (en) * 2000-07-13 2002-01-31 Yi Jin Synthesis and antiviral evaluation of nucleic acid based (nab) libraries
AUPR079700A0 (en) * 2000-10-17 2000-11-09 Alchemia Pty Ltd Combinatorial libraries of monosaccharides
AUPR084400A0 (en) * 2000-10-18 2000-11-09 Alchemia Pty Ltd Immunoadjuvant systems

Similar Documents

Publication Publication Date Title
JP2005526813A5 (enExample)
CA2389681A1 (en) Npy y5 antagonist
JP2005532287A5 (enExample)
HUP0500457A2 (hu) Polialkilén polimervegyületek, ilyeneket tartalmazó készítmények és azok alkalmazása
HUP0401729A2 (hu) IV típusú foszfodiészteráz inhibitor hatású alkin-aril-naftiridin-4(1H)-on-származékok és ezeket tartalmazó gyógyszerkészítmények
HUP0302943A2 (hu) Új heterociklusos vegyületek, előállításuk és alkalmazásuk gyógyszerekként, különösen antibakteriális szerekként
CA2457054A1 (en) Activator of peroxisome proliferator-activated receptor .delta.
TW200738682A (en) Isoquinoline derivatives
JP2008510828A5 (enExample)
JP2005502621A5 (enExample)
JP2009500423A5 (enExample)
MY134582A (en) New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof as medicaments
JP2008505157A5 (enExample)
HUP0002404A2 (hu) Aminosavszármazékok, hatóanyagként ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukra és alkalmazásuk
JP2004532346A5 (enExample)
JP2011506490A5 (enExample)
JP2005536531A5 (enExample)
TW200616636A (en) Novel compounds
JPH10121091A5 (enExample)
JP2005529910A5 (enExample)
HUP0204501A2 (hu) Gyűrűs vegyületek, ezeket tartalmazó gyógyászati készítmények, valamint eljárás a vegyületek előállítására és alkalmazásuk
JP2007507472A5 (enExample)
NO20073736L (no) Nye 3-fenylpropionsyrederivater for behandlingen av diabetes
JP2003535868A5 (enExample)
CA2531484A1 (en) Novel bioisosteres of actinonin